Browsing Tag

PRNewswire

54791 posts
ARCHIPELAGO INTERNATIONAL CONTINUES EXPANSION IN THE CARIBBEAN AND LATIN AMERICA WITH PLANNED NEW OPENINGS, MULTIPLE SIGNINGS AND NEW CORPORATE OFFICES IN PUNTA CANA

ARCHIPELAGO INTERNATIONAL CONTINUES EXPANSION IN THE CARIBBEAN AND LATIN AMERICA WITH PLANNED NEW OPENINGS, MULTIPLE SIGNINGS AND NEW CORPORATE OFFICES IN PUNTA CANA

PUNTA CANA, Dominican Republic, May 24, 2024 /PRNewswire/ — Last week, at…
Bybit Web3 Announces Upcoming IDO for Aperture Finance, Simplifying Web3 Finance

Bybit Web3 Announces Upcoming IDO for Aperture Finance, Simplifying Web3 Finance

DUBAI, UAE, May 24, 2024 /PRNewswire/ — Bybit Web3, the Web3 division…
K-Pet develops disease prevention solutions to extend the healthy life of pets

K-Pet develops disease prevention solutions to extend the healthy life of pets

SEOUL, South Korea, May 24, 2024 /PRNewswire/ — On the 23rd, K-PET…
CNFinance to Hold Annual General Meeting on June 7, 2024

CNFinance to Hold Annual General Meeting on June 7, 2024

GUANGZHOU, China, May 24, 2024 /PRNewswire/ — CNFinance Holdings Limited (NYSE: CNF)…
Atour Unveils Sustainability Records in 2023 With Milestone ESG Report

Atour Unveils Sustainability Records in 2023 With Milestone ESG Report

SHANGHAI, May 24, 2024 /PRNewswire/ — May 23, Atour Lifestyle Holdings Limited…
36Kr Hosts "AI Partner • Advanced Productivity" Conference

36Kr Hosts "AI Partner • Advanced Productivity" Conference

BEIJING, May 24, 2024 /PRNewswire/ — 36Kr Holdings Inc. ("36Kr" or the…
Lights On! Harbour City transforms for Vivid Sydney 2024

Lights On! Harbour City transforms for Vivid Sydney 2024

Download high-res images & broadcast-quality vision of Vivid Sydney 2024 HERE Tickets…
Menarini Group Presents Updated Data from ELECTRA and ELEVATE Combination Studies of Elacestrant (ORSERDU®) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the ASCO 2024 Annual Meeting

Menarini Group Presents Updated Data from ELECTRA and ELEVATE Combination Studies of Elacestrant (ORSERDU®) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the ASCO 2024 Annual Meeting

The ELECTRA and ELEVATE studies were designed to overcome different resistance mechanisms…